Active Ingredient(s):Telbivudine FDA Approved: * October 25, 2006 Pharm Company: *IDENIX PHARMA Category:Hepatitis
Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (European Union) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance. However, HBV signature resistance mutation M204I (a change from methionine to isoleucine at positi...
* May have multiple approval dates, manufacturers, or labelers.